Vesugen

Vesugen

Vesugen is a short-chain tripeptide of Russian bioregulator origin, developed as part of the Khavinson peptide series. It is classified as a vascular bioregulator, with preclinical research suggesting a role in supporting endothelial function and vascular tissue homeostasis. Vesugen has been investigated for its potential to modulate gene expression in vascular smooth muscle and endothelial cells, making it a subject of interest in cardiovascular and ageing research.

Mechanism of Action

Vesugen is hypothesised to act as a peptide bioregulator by interacting with specific DNA promoter regions in vascular tissue, thereby influencing the transcription of genes associated with endothelial integrity and smooth muscle function. This epigenetic-like mechanism is consistent with the broader Khavinson bioregulator model, in which short peptides restore age-related decline in tissue-specific gene expression.

Research Applications

• Vascular endothelial function and integrity studies
• Cardiovascular ageing and longevity research
• Smooth muscle cell gene expression modelling
• Peptide bioregulator mechanism investigation
• Angiogenesis and microcirculation research

Specifications

• Molecular Formula: C₁₅H₂₆N₄O₈
• Molecular Weight: 390.39 g/mol
• CAS Number: 204271-66-9
• Purity: ≥98%
• Form: Lyophilised powder
• Storage: -20°C
• Shelf Life: 24 months

This product is intended for legitimate laboratory and analytical research use only. Not for human use, veterinary use, or consumer use. Not for diagnostic or therapeutic purposes.